clinical

ALS Clinical

Approved for sale in Europe, CE Registration #518356 .

"US Investigational Device, not currently available for sale in the US .

Initial study of the device in ALS provided the feasibility of using diaphragmic pacing to slow the decline in a patient's Forced Vital Capacity and delay the onset of respiratory failure. Data from our pilot study revealed the average pre-implant rate of decline was calculated at -2.8% per month and for patients with at least 9 months post-implant follow-up the rate improved to
-1.0% per month.

We are also investigating to determine if the NeuRx DPS™ may be effective in ventilatory support of patients with ALS either decreasing or eliminating the need for negative or positive pressure mechanical ventilation.

Download the ALS Patient/Caregiver Brochure [PDF]

View ALS Patient/Caregiver Video

Or for information about the open ALS clinical trial please contact:

Study Hospital Name Coordinators

#1

University Hospitals of Cleveland
Cleveland, OH 44106
Mary Jo Elmo, ACNP
Office (216) 844-8594
maryjo.elmo@uhhs.com
#2 Johns Hopkins University
Baltimore, MD 21287
Laura Clawson-Research Coordinator
Office (410) 955-8511
lclawson@jhmi.edu
#3 Stanford University
Stanford, CA 94305
Shirley Paulose- Research Assistant, Neurology
Office (650) 724-3792
spaulose@stanford.edu
#4 Methodist Neurological Institute
Houston, Texas 77030
Angela Lavespere-Research Coordinator (ALS)
Office (713) 441-3420
ALavespeare@tmh.tmc.edu
#5 Henry Ford Health System
Detroit, MI. 48202
Helen Foley- Research Coordinator
Office (313) 916-3955
helen@neuro.hfh.edu
#6 Mayo Clinic
Jacksonville, FL 32224
Karen Overstreet- ALS Research Coordinator
Office (904) 953-8946
Overstreet.Karen@mayo.edu
#7 CaliforniaPacific Medical Center (CPMC)
San Francisco, CA 94115
Dallas Forshew- Manager, ALS Research  
Office (415)600-3604
forshed@cpmcri.org